These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1149880)

  • 1. Synthesis of some derivatives of 19,20-di-norprostanoic acid.
    Valcavi U; Innocenti S; Zabban GB; Pezzini C
    Farmaco Sci; 1975 Jul; 30(7):527-35. PubMed ID: 1149880
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and platelet aggregation inhibitory activity of 10-oxa and 10-thia prostanoic acid derivatives.
    Das J; Vu T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():788-93. PubMed ID: 2960192
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation.
    Ghali NI; Venton DL; Hung SC; Le Breton GC
    J Med Chem; 1983 Jul; 26(7):1056-60. PubMed ID: 6408259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of (+)-prostanoic acid (1).
    Sakai K; Inouye K; Nakamura N
    Prostaglandins; 1976 Sep; 12(3):399-401. PubMed ID: 968053
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of (+/-) 8,12-trans-delta5-en-cis-9-keto-13,14-en-trans-15-R,S-hydroxyprostanoic acid methyl ester.
    Traverso G; Pirillo D; Damonti E; Rescia G
    Farmaco Sci; 1978 Jul; 33(7):562-4. PubMed ID: 744254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregation.
    Venton DL; Enke SE; Le Breton GC
    J Med Chem; 1979 Jul; 22(7):824-30. PubMed ID: 109614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin isosteres. 1. (8-Aza-, 8,10-diaza-, and 8-aza-11-thia)-9-oxoprostanoic acids and their derivatives.
    Smith RL; Lee T; Gould NP; Cragoe EJ
    J Med Chem; 1977 Oct; 20(10):1292-9. PubMed ID: 198545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins and congeners. 11. Synthesis of dl-13-hydroxyprostanoic acids.
    Wissner A
    J Org Chem; 1977 Jan; 42(2):356-8. PubMed ID: 830868
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and antihyperlipidemic activity of piperic acid derivatives.
    A R; Bao N; Sun Z; Borjihan G; Qiao Y; Jin Z
    Nat Prod Commun; 2015 Feb; 10(2):289-90. PubMed ID: 25920263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Further observations of the inhibitory effect of the disodium salt of 9-hydroxy-8,12-trans-19,20-bis-norprostanoic acid (rosaprostol) on gastric secretion].
    Adami M; Scarpignato C; Signorini G; Coruzzi G; Bertaccini G
    Farmaco Prat; 1984 Nov; 39(11):409-16. PubMed ID: 6526080
    [No Abstract]   [Full Text] [Related]  

  • 11. Some biological activities of a series of 9a-homo-9,11-epoxy prostanoic acid analogues.
    Hall DW; Funcke AB; Jaitly KD
    Prostaglandins; 1979 Aug; 18(2):317-30. PubMed ID: 523684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-aggregatory prostanoids. Part I.
    Korbut R; Gryglewski RJ
    Acta Physiol Pol; 1985; 36(5-6):293-302. PubMed ID: 3915631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of (+/-)-8,12-trans-delta5-en-cis-9-KETO-14,15-en-trans-16-R,S-hydroxyprostanoic acid methyl ester.
    Pirillo D; Traverso G
    Farmaco Sci; 1976 Jun; 31(6):468-70. PubMed ID: 1278365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The gastroprotective and antiaggregant activities of 13-azaprostanoids].
    Kuz'mitskiĭ BB; Mizulo NA; Romanova VN; Malaeva LP; Khlebnikova TS; Lakhvich FA
    Eksp Klin Farmakol; 1992; 55(6):27-8. PubMed ID: 1305869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.
    Le Breton GC; Venton DL
    Adv Prostaglandin Thromboxane Res; 1980; 6():497-503. PubMed ID: 7386283
    [No Abstract]   [Full Text] [Related]  

  • 16. An easy synthesis of ((+/-)-8,12-trans-delta5-en-cis-11-keto-14,15-yn-16-R,S-hdroxyprostanoic acid methyl ester.
    Traverso G; Pirillo D
    Farmaco Sci; 1976 Apr; 31(4):305-7. PubMed ID: 939329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (+/-)-8,12-trans-delta5-en-cis-11-KETO-14,15-trans-en-16-R,S-hydroxyprostanoic acid methyl ester.
    Traverso G; Pirillo D
    Farmaco Sci; 1976 Jun; 31(6):438-41. PubMed ID: 1278363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-aggregatory prostanoids. Part II.
    Korbut R; Gryglewski RJ
    Acta Physiol Pol; 1985; 36(5-6):303-16. PubMed ID: 3915632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of [17,18-3H] trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor.
    Ghali NI; Kattelman EJ; Hung SC; Schnorf KE; Le Breton GC; Venton DL
    Prostaglandins; 1984 Jun; 27(6):865-76. PubMed ID: 6091182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
    Moriya T; Seki M; Takabe S; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    J Med Chem; 1988 Jun; 31(6):1197-204. PubMed ID: 3373489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.